Stock Analysis

Scotts Miracle-Gro Full Year 2024 Earnings: EPS Misses Expectations

Published
NYSE:SMG

Scotts Miracle-Gro (NYSE:SMG) Full Year 2024 Results

Key Financial Results

  • Revenue: US$3.55b (flat on FY 2023).
  • Net loss: US$34.9m (loss narrowed by 91% from FY 2023).
  • US$0.61 loss per share (improved from US$6.79 loss in FY 2023).
NYSE:SMG Revenue and Expenses Breakdown November 29th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Scotts Miracle-Gro EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates.

The primary driver behind last 12 months revenue was the U.S. Consumer segment contributing a total revenue of US$3.01b (85% of total revenue). Notably, cost of sales worth US$2.62b amounted to 74% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$418.0m (43% of total expenses). Explore how SMG's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in the US.

Performance of the American Chemicals industry.

The company's shares are down 2.6% from a week ago.

Risk Analysis

It is worth noting though that we have found 2 warning signs for Scotts Miracle-Gro (1 is a bit unpleasant!) that you need to take into consideration.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.